Covid-19: Мультидисциплінарні дослідження судово-фармацевтичних ризиків та причинно-наслідкових зв’зків некваліфікованої медичної допомоги пацієнтам під час пандемії

Abstract

A multidisciplinary study was conducted to study the forensic and pharmaceutical risks and to establish the casual relationships of unqualified medical care (medical errors) to patients and the development of diseases during the COVID-19 pandemic. It was substantiated that in the context of the coronavirus pandemic, multidisciplinary research in the field of healthcare combines interdisciplinary links of scientists from around the world in medicine, pharmacy, law, economics on good medical practice, pharmaceutical provision and availability of clinical and pharmacological, nomenclature and legal groups for all contingents of patients. It was noted in examples from forensic and pharmaceutical practice that unqualified medical care (medical or medical errors) can lead to varying degrees of severity of health disorders, improper performance of professional duties by a medical or pharmaceutical worker contains in its content forensic pharmaceutical risks provision of medicines, ultimately leads to health offenses. Causation has been shown to be associated with pandemics of coronavirus infection in the context of COVID, long-COVID and post-COVID health disorders. It was noted that the pandemic to COVID-19 and its consequences have three characteristic features of traumatic events: unpredictability, uncontrollability, threat of death or serious injury. The experience of the USA, France, Israel, China, EU countries on the example of Estonia on the organization of the healthcare system during the COVID-19 pandemic were studied. It was shown that the commercialization of the system of legal relations "doctor-patient-pharmacist-lawyer" affects the quality of medical practice and the availability of medicines for patients. Emphasis was placed on the continuing of professional development for healthcare professionals in the casual relationship of unqualified medical care (medical errors) to patients and the development of COVID, long-COVID and post-COVID diseases during the COVID-19 pandemic. The prospects of using Estonia's experience in the digital healthcare system, which covers all medical institutions in the country and every citizen were mentioned.